Axon price target raised to $726 from $585 at Barclays

Barclays raised the firm’s price target on Axon (AXON) to $726 from $585 and keeps an Overweight rating on the shares following the Q4 report. Axon’s strength continued with the third consecutive year of over 30% sales growth, the analyst tells investors in a research note. The firm says T10 orders continue to outpace T7 orders and 10 artificial intelligence Era Plan deals closed in Q4.